InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Litchman Manuel MD, Chairman & CEO. Insider active across 1 companies, notably Mustang Bio, INC.. In total, 8 reports have been published. Total volume traded: €673k. The latest transaction was filed on 27 October 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€125,51665,000 shares@ €1.9312.74% mcap36.7% of flow
COMMON STOCK
SEC:0001104659-21-135706·
Ideal exit: 24 Jul 2022 (T+270)
€125,51665,000 shares@ €1.9312.74% mcap18.3% of flow
COMMON STOCK
SEC:0001104659-21-135706:0·
Ideal exit: 24 Jul 2022 (T+270)
€5,9992,746 shares@ €2.18450.13% mcap1.8% of flow
COMMON STOCK
SEC:0001104659-21-119384·
€5,9992,746 shares@ €2.18450.13% mcap0.9% of flow
COMMON STOCK
SEC:0001104659-21-119384:0·
€210,93086,206 shares@ €2.44684.60% mcap61.6% of flow
COMMON STOCK
SEC:0001104659-21-100783·
Ideal exit: 26 Apr 2022 (T+270)
€210,93086,206 shares@ €2.44684.60% mcap30.8% of flow
COMMON STOCK
SEC:0001104659-21-100783:0·
Ideal exit: 26 Apr 2022 (T+270)
061,000 shares0
COMMON STOCK
SEC:0001104659-21-090242·
061,000 shares0
COMMON STOCK
SEC:0001104659-21-090242:0·
8 of 8 declarations
About Litchman Manuel MD
Manuel MD Litchman serves as the President and CEO of MUSTANG BIO, INC. He is responsible for the strategic direction and operations of the company. Litchman plays a key role in developing new initiatives and optimizing the services offered by MUSTANG BIO.
